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 During reproduction, animals must allocate their own metabolic resources to 
provide their progeny with ample energy. In most metazoans, vitellogenesis is the process 
where lipids are allocated to embryos for proper development via lipoprotein-like 
carriers. How lipid metabolism pathways are controlled by developmental or 
environmental cues remains an open question in cell biology. This thesis adds novel 
insights into the mitogen activated kinase kinase kinase (MEKK-3) as an essential 
regulator of C. elegans lipoprotein expression that globally controls lipid homeostasis, 
development, and animal growth. Here, I provide evidence of genetic interactions 
between mekk-3 and flr-2, a gene that functions in fluoride toxicity and previously 
described to have implications in defecation signaling, in addition to fshr-1 (follicle 
stimulating hormone receptor 1). Therefore, I propose that MEKK-3 functions in parallel 















1.1 The necessity of energy homeostasis and its role in animal development and 
health 
In order to ensure survival and viability, animals must efficiently manage their 
energy resources to maintain homeostasis. The balance of energy resources between 
somatic and germline cells dictates animal survival and overall fitness. Many species 
have developed sophisticated mechanisms to transfer energy towards reproduction, a 
process that is tightly regulated to maintain the balance between somatic health and 
reproductive fitness. Subsequent anomalies in these mechanistic controls result in 
sterility, diminished lifespans, stunted growth, and other developmental defects (Chen 
et al. 2020). In humans, energy homeostasis involves internal feedback signals that 
utilize endocrine effector pathways that other tissue systems (Shin, Zheng, & 
Berthoud, 2009). As such, energy homeostasis is maintained by a complex network of 
signaling pathways that function in multiple tissues to control responses to changes in 
feeding behavior, diet, and energy storage. (Jones & Ashrafi, 2009). Both on the 
macromolecular and organ system levels, energy expenditure, food intake, and fat 
storage are impacted by a variety of environmental factors, including diet and stress, 
which may determine overall fitness and survivability. Nutrient sensing and inter-
tissue signaling are among some of the evolutionary developed processes to maintain 
order.   
Disruption of metabolic balance may result in disease formation, including 
obesity, type 2 diabetes, and cancer (Kopelman, 2000). In the public health sector, a 





necessity in uncovering the pathways that regulate lipid metabolism. As energy 
homeostasis is governed by a series of complex networks, using organisms with 
similar physiology and regulatory pathways to humans have proven to be crucial 
models in understanding conserved components of lipid homeostasis. Early studies of 
conserved fat-regulatory genes and pathways in mouse models have yielded 
fundamental insights regarding the pathophysiology of metabolic diseases (Kennedy 
et al. 2010). Expanding this research to other genetic models may reveal new 
connections between key components and tissues, leading to a more comprehensive 
understanding of lipid metabolism and its role in human disease. 
 
1.2 Vitellogenesis in C. elegans 
Caenorhabditis elegans, a member of the Rhabditidae family, is a microscopic 
and transparent nematode widely used as a model organism in animal genetic and 
molecular biology research. As a simple and genetically tractable organism, C. 
elegans boasts a small 100 Mbp genome in addition to containing genes that are 
orthologous to other mammalian species. Moreover, as self-fertilizing 
hermaphrodites, C. elegans reaches sexually-mature adulthood within 72 hours and 
have a short life cycle which is useful for studying development (Silverman 1999). 
The species is advantageous over other cell-based models for studying lipid 
homeostasis since the worm possess a sophisticated inter-tissue endocrine system that 
coordinates conserved signaling pathways.  
Lipids are among the four classes of macromolecules and serve many essential 





a form of stored energy, and immune cell plasticity is dependent on lipid-based 
recognition (Hubler & Kennedy, 2017). The proteins involved in lipid biogenesis, 
degradation, and transportation are highly conserved between C. elegans and 
mammals.  
Mammals utilize lipoprotein particles to transport lipids between tissues via the 
bloodstream. Specific proteins, such as low-density lipoproteins (LDL), assemble and 
distribute triglycerides and cholesterol to peripheral tissues in large particles for a 
myriad of metabolic processes (Diffenderfer & Schaefer, 2014). In many metazoans, 
energy resources are diverted towards reproduction using vitellogenin lipoproteins.  
In C. elegans, the vitellogenins are encoded by vit-1-6, which are orthologous to 
the mammalian apolipoproteins, and are responsible for transporting large amounts of 
lipids in the form of yolk between tissues. The vitellogenin lipoproteins are 
synthesized in the adult intestine, secreted, and captured by the oocytes in the 
germline. This essential process, which is found in most metazoans, provides 
embryos with the necessary nutrients for proper development (Dowen & Ahmed, 
2019).  How metabolic signals are coordinated at the molecular level to maintain 
reproductive fitness and somatic maintenance is a process essential for survival. 
Nonetheless, the identities and functionality of these signaling components remains 
largely unknown. 
 
1.3 MEKK-3 as a regulator of vitellogenesis in C. elegans 
We previously performed an RNAi screen to identify new candidate genes that 





This approach uncovered a role for MEKK-3, the C. elegans orthologue of MEKK3 
mitogen-activate protein kinases (MAPK), in the intestine. Protein kinases are a large 
family of enzymes that modify target proteins via phosphorylation. This biochemical 
process involves the covalent attachment of phosphate from a high energy molecule 
(e.g. ATP) to the side chains of either serine, threonine, or tyrosine of target proteins 
intercellularly. The proteins modified by phosphorylation are commonly changed 
either in activation function, cellular localization, or tagged for degradation.  As a 
modifier of enzyme activity, kinases are involved in a myriad of signal transduction 
pathways that regulate homeostatic processes, including growth and aging by 
modulating the activity of substrate proteins. These substrate proteins may include 
other protein kinases, transcription factors, and membrane bound proteins. In a 
converse manner, protein phosphatases serve to remove the attached phosphates, 
thereby undoing the effect of kinases. The duality between kinases and phosphatases 
serves as a dynamic process in which cellular behavior can attune to environmental 
changes (Wang & Cole, 2014).  
Within the serine-threonine kinase gene family, MAPKs are responsible for 
directing cellular responses to a variety of external stimuli. Canonically, MAPKs 
function as enzymes through a regulatory phosphorelay system in which a series of 
protein kinases phosphorylate and activate one another. The downstream kinase (e.g. 
MAPK) acts as a target for the upstream kinase (e.g. MAPKK). The kinases can be 
activated via phosphorylation through their interaction with a GTP-binding protein 





including mitogens, osmotic stressors, cytokines, and heat shock effectors (Cargnello 
& Roux, 2011) (Johnson & Lapadat, 2002).  
MAPK signaling occurs in response to both extracellular and intracellular stimuli 
that alters metabolism on the cellular, tissue, and organismal levels. MAPK-signal 
transduction is necessary in physiological development and metabolic adaptation, but 
improper signaling triggers the formation of specific pathological disorders called 
metabolic syndrome (Gehart et al. 2010). Dysregulation of MAPK signaling often 
forms the impetus for cancer and related diseases (Braicu et al. 2019).  
Understanding the MAPK-signaling mechanisms involved in cellular metabolism 
may help to elucidate their relationship to metabolic syndrome. MEKK-3, a 
conserved component of MAPK signaling, is involved in the regulation of 
vitellogenesis, but how it controls lipid homeostasis is poorly understood. Previous 
studies of MEKK-3 in mice revealed kinase regulation of Krüppel-Like Factors 
(KLFs), which are zinc-finger transcription factors that regulate cellular and 
metabolic pathways (Zhou et al. 2016). In other organisms like yeast, MAPK 
signaling has been discovered to be essential for stress survival induction via 
regulation of TORC1 signaling, a widely characterized pathway involved in nutrient 
and energy sensing (Rosseau & Bertolotti, 2016).  
It was previously reported that knockdown of mekk-3 in C. elegans results in 
increased longevity, decreased fat storage, and upregulation of genes involved in fatty 
acid degradation (Chamoli et al. 2014). Here, I demonstrate that MEKK-3 functions 
in the intestine to regulate vitellogenin expression and promote growth. Additionally, 





that MEKK-3 may work in parallel to a hormonal signaling pathway (FLR-2/FSHR-
1) to regulate growth and vitellogenin expression. My findings suggest that MEKK-3 
promotes growth and coordinates lipid metabolism pathways, which is opposed by 
the FLR-2/FSHR-1 signaling pathway. Identification of the downstream effectors of 
MEKK-3 signaling may result in the development of novel therapies for cancer, 





















2 | MATERIALS AND METHODS 
 
2.1 Worm strains and growth conditions 
 
The C. elegans wild-type strain used in this study is N2 Bristol. All strains were 
cultured using standard methods (Brenner 1974). 
 
2.2 CRISPR/Cas9  
 
The following sgRNA sequences were used to generate the rhd109 and rhd110 
mekk-3 mutant alleles, respectively: 
CCTCCTATTGCGAGATGTCTTGTCCTCTGAATGCATTTTTGAGTTTAAGAGCT
ATGCTGGAAACAG (rhd109), CCTCCTATTGCGAGATGTCTTGAATGTGTCTGA 
AGGGCGCAGGTTTAAGAGCTATGCTGGAAACAG (rhd110)  in pMLS256. The 
CRISPR/Cas9 injection mix was composed of 60 ng/ul Cas9/sgRNA plasmid as 
previously described (Ward 2014). 
 
2.3 RT-qPCR  
 
L1 animals were synchronized via egg prep and grown on OP50 seeded NGM 
plates for ~ 72 hours at 20℃ until early adulthood was reached. Animals were harvested 
in M9 buffer, washed, and flash frozen. RNA was isolated using Trizol and gDNA was 
eliminated using the TURBO DNA-free kit per the manufacturer’s instructions (Thermo 
Fisher). cDNA was synthesized by oligo(dT) priming using the SuperScript III kit per the 
manufacturer’s instructions (Thermo Fisher). Quantitative PCR was performed on a 
QuantStudio 6 Flex Real-Time PCR System using the PowerUp SYBR Green master mix 





2.4 Growth Assays 
 
The strains were chunked to fresh NGM plates seeded with OP50 to allow for 
fresh egg lays for 24 hours. Embryos were picked to newly seeded NGM plates at around 
100 eggs per plate. Worms were allowed to grow at 20℃, monitored at the same time 
point each day, and any observed adults were picked off and counted towards the % adult 
data set. 
 
2.5 Body Size Assays 
 
The strains were chunked to fresh NGM plates seeded with OP50 to allow for 
well-fed worms. L4s were picked to new seeded NGM plates at around 50 animals per 
plate. Worms were allowed to grow at 20℃ for 24 hours until they reached gravid 
adulthood. Adults were picked into 0.1% levamisole on 2% agarose pads. Worms were 
imaged with a 10X objective on a Nikon stereo-microscope with fluorescence running 
Nikon NIS Elements Viewer software. Worm image outlines were traced using the wand 
tool, and the respective area were quantified in Image J.  
 
2.6 Generation and imaging of transgenic strains  
 
The mekk-3 intestinal rescue construct was generated by fusing the vha-6 
promoter (chromosome II: 11,438,422–11,439,355; WS251) to a mCherry::his-58::SL2 
cassette fused to the mekk-3 cDNA (chromosome IV: 325,059–330648). The mekk-3 
hypodermal rescue construct was generated by fusing the col-10 promoter (chromosome 
V: 9,165,291-9,166,643) to a mCherry::his-58::SL2 cassette fused to the mekk-3 cDNA 
(chromosome IV: 325,059–330648). The constructs were microinjected (20 ng/μL) along 





specific transsplice site was incorporated to verify the tissue specificity of mekk-3 
expression, which can be visualized from mCherry::his-58 expression. The individual 
DNA fragments (promoters, mCherry::his-58::SL2 cassette, and mekk-3) were amplified 
via PCR (Phusion, New England Biolabs), assembled into the pCFJ151 plasmid by 
Gibson assembly (New England Biolabs), and verified by Sanger sequencing. All 
transgenic worms carrying either the Pvit-3::GFP and myo2::mCherry were imaged with 
a 1X objective on a Nikon stereo-microscope with fluorescence running Nikon NIS 
Elements Viewer software. 
 
2.7 Generation and imaging of transgenic strains  
 
Mutagenesis of mekk-3(rhd109) was performed using EMS (Sigma-Aldrich). 
Briefly, synchronized animals were washed three times with M9 buffer containing 0.01% 
Tween-20 before resuspending them in 47 mM EMS in M9 buffer. Animals were rotated 
for 4 h at 20℃, washed three times with M9 buffer containing 0.01% Tween-20, dropped 
onto NGM plates seeded with OP50 bacteria, and grown for 24 h before isolating the 
embryos by bleach preparation. Synchronized F1 larvae were grown on NGM OP50 
plates for ~ 72 h at 20℃, and any GFP-positive suppressors were picked. Each pool of F1 
gravid adults was individually bleach-prepared and synchronized in M9 buffer (dominant 
alleles or haploinsufficiency). The F2 animals were grown for ~ 72 h at 20℃ on NGM 
OP50 plates, and the GFP-positive suppressors were picked (recessive alleles). Strains 
carrying the mekk-3 suppressor alleles were then backcrossed to mgIs70;mekk-3(rhd109) 
twice, and ~ 50 recombinants arising from the second backcross were picked to 
individual plates. Animals were allowed to starve, pooled, and genomic DNA was 





3 | RESULTS 
3.1 Knockout of mekk-3 causes severe vitellogenesis defects 
To assess how loss of MEKK-3 alters the overall physiology of C. elegans, we 
generated two mutant alleles in the mekk-3 gene, rhd109 and rhd110, using 
CRISPR/Cas9. The CRISPR event was performed in a strain carrying the mgIs70 
transgene, which is a genetically tractable vitellogenesis reporter that consists of the 
promoter of the vit-3 gene fused to GFP (Pvit-3::GFP). In wild-type C. elegans, the 
reporter is turned on at the L4 to adulthood transition and is expressed solely in the 
intestine of the reproductive adult. Both mekk-3 mutants display a severe loss of Pvit-
3::GFP expression in the intestine (Fig. 1A), indicating that MEKK-3 is required for 
vitellogenin expression. In order to confirm that MEKK-3 kinase activity is required, we 
generated two mutant strains targeting the activation loop of the protein kinase domain in 
the Pvit-3::GFP reporter background. We found both the mgIs70; mekk-3(P269S) and 
mgIs70 mekk-3(P269S E270K) mutants properly expressed the vitellogenin reporter (Fig. 
1B, data by Natalie Cohen). This suggests that mekk-3 functions in a kinase-independent 
role to regulate vitellogenin expression.  
Upon observation that mekk-3 mutants display severe vitellogenesis defects, we 
generated a transgenic tissue-specific rescue strains that restore mekk-3 expression 
specifically in the intestine or the hypodermis (Fig. 1C). Although mekk-3 is expressed 
systemically, including the body wall musculature, neurons, seam cells, and vulval 
muscles, we chose the intestine and hypodermis as candidate tissues based on a 
previously identified cell non-autonomous signaling pathway that originates in the 







Figure 1. Knockout of mekk-3 causes severe vitellogenesis defects: (A) Knockout of mekk-3 in Pvit-3::GFP 
reporter animals prevents transcription of vitellogenins. mekk-3(rhd109) is a small deletion of mekk-3 and mekk-
3(rhd110) is a large deletion. (B) Disruption of the mekk-3 activation loop in P269S or P269S, E270K does not 
disrupt vitellogenin transcription. (C) Rescue of WT mekk-3 in the intestine and hypodermis shows that MEKK-3 
operates in the intestine to regulate vitellogenin reporter expression. (D) Systemic or intestinal, but not 






Intestine-specific rescue of mekk-3 completely restored vitellogenin expression to that of  
wild type expression. Conversely, the hypodermal-rescued rhd109 animals exhibit a 
similar vitellogenesis defect to that observed in the rhd109 mutant (Fig. 1C).  
The rescue experiment suggest that MEKK-3 functions in the intestine to regulate 
vitellogenin expression. However, in order to recapitulate these observations, we 
quantified the expression of the vit-genes (vit-1-6) after tissue-specific knockdown of 
mekk-3 by RNAi using RT-qPCR. Expectedly, systemic knockdown of mekk-3 results in 
a major downregulation of vit-1 and vit-3/4/5. Intestinal specific knockdown of mekk-3 
results in a similar downregulation of vit genes while hypodermis-specific RNAi of mekk- 
3 did not alter vit gene expression (Fig. 1D). Together, our results indicate that MEKK-3 
functions exclusively in the intestine to promote vitellogenin expression. 
 
3.2 Loss of mekk-3 causes severe growth and developmental defects  
As canonical MAPK signaling is activated by the binding of an extracellular 
ligand and the induction of a phosphorylation cascade that transduces a signal to activate 
transcription of genes necessary for cell division and growth (Johnson & Lapadat, 2002). 
We suspect that MEKK-3 may take part in a similar pathway. To further characterize the 
mekk-3 mutants, we performed growth assays to quantify the rate at which mutant 
animals reached adulthood relative to wild-type C. elegans. Wild-type C. elegans animals 
reach adulthood from embryo within 72 hours, however, both rhd109 and rhd110 
mutants were unable to reach adulthood within 72 hours, and only 20-30% of the 
population reached adulthood after 14 days (Fig. 2A).  Additionally, we found rhd109 






Figure 2. Loss of mekk-3 causes severe growth and developmental defects: (A) N2, mekk-3(rhd109), and 
mekk-3(rhd110) embryos (≈100 per strain) were picked to OP50 seeded NGM plates. Gravid adults were picked 
off plates and recorded as a percentage of the population at a given time point. Data are the mean ± SEM. (B) 
N2, mekk-3(rhd109), and mekk-3(rhd110) L4s (≈50 per strain) were picked to OP50 seeded NGM plates. Gravid 
adults were picked to 0.1% levamisole, imaged, and analyzed using Image J. (C) Intestinally rescued mekk-
3(rhd109) are able to reach wild-type growth rates. Hypodermal-rescued mekk-3(rhd109) exhibit mutant growth 
defects. (D) Intestinally rescued mekk-3(rhd109) are able to partially restore the mutant body size defect. 





In order to further characterize the tissue-specific rescue strains, we also 
performed a growth and body size assay. Intestinally-rescued rhd109 animals are able to 
reach wild-type growth rates, with 100% adulthood achieved within 96 hours. 
Hypodermal-rescued rhd109 animals phenocopy the mekk-3(rhd109) growth defect and 
are developmentally delayed (Fig. 1C).   
In reciprocating the restored vitellogenesis phenotype observed in Figure 1C, 
intestinally-rescued rhd109 mutants exhibit a partial reversal of the body-size defect in 
mekk-3(rhd109) animals. We observe the rhdEx100 clone to have a stronger reversal of 
the body-size defect compared to rhdEx99, suggesting discrepancies in expression levels 
between the strains. Hypodermal-rescued rhd109 mutants exhibit the same body-size 
defect observed in mekk-3(rhd109) animals. Our analyses of these rescue alleles 
recapitulate that MEKK-3 functions in the intestine to support growth, suggesting that 
MEKK-3 may operate in a larger pathway that could transcriptionally regulate genes 
required for animal development and growth.  
 
3.3 Identifying targets of MEKK-3 signaling 
Our data revealed a cell-autonomous role for MEKK-3 in intestinal lipid 
homeostasis and organismal growth, possibly by regulating other lipid metabolism 
pathways. To identify factors that act downstream or parallel to MEKK-3 signaling, we 
subjected mgIs70: mekk-3(rhd109) animals to EMS mutagenesis to isolate secondary 
mutations that suppress the growth, body size, and vitellogenesis defects associated with 





3(rhd109) strain to eliminate background mutations and subjected to high throughput 
DNA sequencing (Tables 1,2).  
Several deleterious nonsense mutations were identified, including flr-2 and fshr-1, 
which we hypothesize to function genetically downstream or in parallel to mekk-3 to 
regulate lipid homeostasis (Tables 1, 2). We performed an RNAi screen against all 
candidate genes identified by whole genome sequencing and found that knockdown of 
flr-2 and fshr-1 specifically suppressed the mekk-3(rhd109) vitellogenesis defects, 
indicating that these two mutations were causative for the suppression phenotype.  Based 
on homology, we predict that FLR-2 (a secreted glycoprotein hormone) may be a ligand 





















Tables 1 and 2. Mutations found in mekk-3 suppressor strains: Two strains of mekk-3 suppressors were 
backcrossed 2x and sequenced. Across both, several premature stop mutations were elucidated. These 
mutations code for flr-2 and fshr-1, which could encode proteins that function in concert with MEKK-3 to regulate 





3.4 flr-2 suppresses mekk-3 growth, body size, and vitellogenin defects  
To recapitulate our finding that the flr-2(rhd117) mutations suppresses the mekk-
3(rhd109) mutant defects in growth, body size, and lipoprotein expression, we crossed 
the previously identified flr-2(ut5) mutation into the mekk-3(rhd109) background. Both 
the flr-2(ut5) and flr-2(rhd117) mutations suppress the vitellogenin defects that result 
from loss of mekk-3 (Fig. 3A). While the mekk-3(rhd109) mutant fails to develop to 
adulthood within the first 5 days of growth, we observed that both the flr-2(ut5) and flr-
2(rhd117) mutations similarly suppress the mekk-3 growth defect, as all animals reach 
adulthood within 96 hours (Fig. 3B). Additionally, the flr-2(ut5) and flr-2(rhd117) 
mutations suppress the body size defects that result from loss of mekk-3 (Fig. 3C).  
 
3.5 fshr-1 suppresses mekk-3 growth, body size, and vitellogenin defects  
To investigate whether fshr-1(rhd118) mutations suppresses the mekk-3(rhd109) 
defects in growth, body size, and lipoprotein expression, we crossed the previously 
identified fshr-1(ok778) mutation into the mekk-3(rhd109) background. Both the fshr-
1(ok778) and fshr-1(rhd118) mutations suppress the vitellogenin defects that result from 
loss of mekk-3 (Fig. 4A). While the mekk-3(rhd109) mutant fails to develop to adulthood 
within the first 5 days of growth, we observed that both the fshr-1(ok778) and fshr-
1(rhd118) mutations similarly suppress the mekk-3 growth defect, as all animals reach 
adulthood within 96 hours (Fig. 4B). Additionally, the fshr-1(ok778) and fshr-1(rhd118) 













Figure 3. flr-2 suppresses mekk-3 growth, body size, and vitellogenin defects: (A) flr-2(ut5) and flr-2(rhd117) 
partially suppresses the mekk-3(rhd109) vitellogenin defect. (B) flr-2(ut5) and flr-2(rhd117) suppresses the growth 
defect in mekk-3(rhd109). Suppressed animals are able to reach 100% adulthood within 96 hours. (C) flr-2(ut5) and 














Figure 4. flr-2 suppresses mekk-3 growth, body size, and vitellogenin defects: (A) fshr-1(ok778) and fshr-
1(rhd118) partially suppresses the mekk-3(rhd109) vitellogenin defect. (B) fshr-1(ok778) and fshr-1(rhd118)  
suppresses the growth defect in mekk-3(rhd109). Suppressed animals are able to reach 100% adulthood within 96 





3.6 flr-3 and flr-4 phenocopy mekk-3  
 Previous research has identified a class of flr (fluoride resistant) mutants that has 
regulatory roles in the C. elegans defecation cycle. flr-1 encodes a two-transmembrane 
ion channel subunit that is a member of the epithelial sodium channel/degenerin 
superfamily and contains C-terminal intracellular phosphorylation sites (Take-uchi et al. 
1998). flr-3 and flr-4 are suspected to encode kinases. However, the location of the flr-3 
mutation has not been identified in the C. elegans genome and its involvement in the 
mekk-3 regulated pathway is still unclear. The flr-4 gene is expressed in the intestine and 
may play larger roles in lipid homeostasis regulation (Take-uchi et al. 2005).  
 In order to investigate the knockout effects of flr-3 and flr-4, we performed 
phenotypic assays on the previously identified flr-3(ut9) and flr-4(ut7) strains. Both flr-
3(ut9) and flr-4(ut7) exhibit the same vitellogenin, growth, and body size defects as 
mekk-3(rhd109). Additionally, the growth rate and body size of flr-4(ut7) appears to 






















Figure 5. flr-3 and flr-4 phenocopy mekk-3: (A) flr-3(ut9) and flr-4(ut7) exhibit a similar vitellogenin defect to that of 
mekk-3(rhd109). (B) flr-3(ut9) and flr-4(ut7) exhibits developmental defects like mekk-3(rhd109). (C) flr-3(ut9) and flr-





4 | DISCUSSION 
 We identified MEKK-3 as an essential regulator of growth and lipid homeostasis 
in C. elegans: knockout of mekk-3 results in a severe loss of vitellogenin expression and a 
dramatic reduction in growth rate and body size. Tissue-specific knockdown and rescue 
experiments revealed that MEKK-3 is sufficient and necessary in the intestine to promote 
vitellogenin expression.  
4.1 Proposed model of mekk-3 regulation of vitellogenesis 
 
To identify targets of MEKK-3 signaling, we subjected the mekk-3 mutants to 
EMS mutagenesis to isolate secondary mutations that suppressed the growth and 
vitellogenesis defects. These mutants were backcrossed, sequenced, and evaluated for 
candidate genes that may genetically interact with mekk-3. Of these candidate genes, fshr-
1, has been previously characterized to play vital roles in the C. elegans immune response 
against gram-negative and gram-positive bacterial pathogens. Furthermore, FSHR-1 acts 
in the intestine as a membrane bound protein and signals in parallel to the p38 MAPK 
pathway to promote transcriptional upregulation of antimicrobial effector molecules 
(Powell, Kim, & Ausubel, 2009). The ligand that binds to FSHR-1 is thought to be a 
heterodimeric glycopeptide hormone orthologous to human Follicle Stimulating 
Hormone ɑ/β. Interestingly, the other gene we identified in our screen was flr-2, which is 
the ortholog of the FSHɑ subunit (Oichi et al. 2009). We demonstrated that flr-2 
suppresses the growth defects of the mekk-3 mutation and hypothesize that the FLR-
2/FSHR-1 binding complex may normally transduce growth-inhibiting signals in wild-





4, which may also encode proteins that have protein kinase activity (Take-uchi et al. 
2005). The exact genomic location and protein product of flr-3 have yet to be identified.  
The MAP2K and MAPK kinases that operate in a canonical MAPK signaling 
pathway have yet to be identified, although we speculate flr-4 to be a potential candidate 
based on homology with human MAP3K. However, as flr-4 is also a membrane bound 
protein that functions in the intestine, it is possible that it may receive an extracellular 
signal to initiate kinase activation of downstream proteins. We hypothesize that the FLR-
2/FSHR-1 signaling pathway works in parallel to the FLR-3/FLR-4/MEKK-3 pathway to 
control growth and lipid homeostasis in C. elegans (Figure 6).  
Proper allocation of resources between somatic and germline cells is necessary for 
survival and reproduction. Vitellogenesis is a vital process responsible for allocating fat 
resources towards reproduction in C. elegans; however, the underlying mechanisms that 
regulate this process have yet to be fully characterized. We have uncovered a new cell-
autonomous role for MEKK-3 in regulation of vitellogenin expression and growth in C. 
elegans. Furthermore, we have identified genetic suppressors of the mekk-3 mutation, 
providing additional insight into a parallel FLR-2/FSHR-1 pathway MEKK-3 may 
interact with in order to regulate growth and vitellogenin expression. This work 
establishes a robust model to further investigate and identify the components of MAPK 











Figure 6. Working Model of MEKK-3 interactions in C. elegans: We suspect that FLR-2 may be the ligand for the 
FSHR-1 receptor, based on structural homology. We have not identified the downstream targets of FSHR-1 in relation 
to the MEKK-3 signaling cascade. MEKK-3 may communicate with downstream MAPK kinases that could converge 
on transcription factors that regulate vitellogenin expression and growth. FLR-2 may be secreted neuronally following 





4.2 Future Directions 
Elucidating additional MAPK proteins involved in vitellogenin regulation and 
identifying what flr-3 encodes for is crucial in piecing together the MEKK3 pathway . 
Furthermore, discerning the role of FLR-4 in MEKK-3 regulation of vitellogenesis is 
crucial towards understanding how this MAPK pathway regulates vitellogenesis. 
Identifying transcription factors regulated by the MEKK-3 pathway will be essential to 
understanding the mechanistic control of vit gene transcription. Ultimately, investigating 
the biochemical interactions between the gene products involved in vitellogenin 
regulation may shed insights into how lipid transport and composition is altered on the 
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